Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study

Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID Paxlovid was associated with a 61% lower risk of hospitalization. CIDRAP

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.

The study was published today in Scientific Reports and adds to the understand of the usefulness of Paxlovid in the Omicron-variant period.

..